Company intelligence / Profile preview

HippoFi

Irvine, California, United Stateshippofi.info ↗

Ownership: Private
Development stage: Commercial

Overview

HippoFi has commercialized several advanced biomaterials for spinal fusion and orthopedic procedures through its subsidiary PUR Biologics. The company has FDA 510(k) clearance for some products such as ActiveOrbTM. It is also developing next-generation regenerative stem cell and growth factor-driven therapeutics targeting osteoarthritis and cartilage regeneration. Clinical results have not been published but the company reports strong sales growth with adoption at major healthcare facilities

Therapeutic areas: Rheumatology
Modalities: AllograftDemineralized extracellular matrixSynthetic bone-forming solutionCellular-derived tissue therapyStem cell therapyGrowth factor-driven therapeutics
Industry: Biotech

Drug pipeline

1 asset

PURamnio

Unknown

Partnerships

Zimmer Biomet – exclusive global license to underlying synthetic biomaterial technology for spine market; joint commercialization agreement with Zimmer overseeing production under the PUR brandBPB Medica – exclusive partnership to launch surgical device "PURmarrow360" in US marketHoag Hospital Newport Beach – clinical collaboration partner mentioned among key alliancesPrecision Spine – industry alliance

Beyond the preview

Go deeper on HippoFi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HippoFi.

Explore the full profile